Granatapfel: Prävention und adjuvante Ernährungstherapie bei Krebserkrankungen

Zusammenfassung

Der Granatapfel ist eine der ältesten Kultur- und Gesundheitsfrüchte der Menschheit. Aber erst in den letzten sieben Jahren rückte er in den Blickpunkt der Forschung. Weit über 200 Veröffentlichungen mit Peer Review sind bislang erschienen. In vitro, in vivo und in klinischen Studien wurden im Granatapfelsaft überzeugende antioxidative, antiinflammatorische, antiarteriosklerotische und antikanzerogene Wirkungen nachgewiesen. Bei 48 Prostatakrebspatienten zeigte sich u.a. eine Vervierfachung der PSA-Verdoppelungszeit. Andere Studien wiesen dem Granatapfelsaft eine ausgeprägte wachstumshemmende Wirkung gegen Lungen-, Darm-, Haut- und Brustkrebs nach. Der auch für Diabetiker gesunde Saft verbesserte deutlich die Myokarddurchblutung bei KHK-Patienten und reduzierte arteriosklerotische Ablagerungen in der Karotis. Er hemmt Entzündungsprozesse (über NF-kappa-B und TNF-alpha) und die Entwicklung von Alzheimer-Demenz. Hierfür verantwortlich scheinen nicht bestimmte isolierte Verbindungen zu sein, sondern die Synergie aller natürlichen Inhaltsstoffe der Frucht. Diese modulieren Zellsignalwege sowie epigenetisch die Genexpression und -regulation. In der Krebshemmung zeigen Granatapfelsaft und fermentierte Granatapfelsaftextrakte eine deutlich höhere Wirksamkeit als isolierte Verbindungen wie Punicalagin, Ellagsäure oder tanninreiche Extrakte.

Abstract

The pomegranate is one of the oldest fruits cultivated for nutritional and health purposes. However, seven years ago science put a focus on its health effects. Far over 200 peer-reviewed studies have been published so far. Pomegranate juice was shown to have in vitro, in vivo and in clinical studies strong anti-oxidative, anti-inflammatory, anti-arteriosclerotic and anti-carcinogenic properties. In 48 patients with prostate cancer the PSA doubling time was quadrupled. In other studies pomegranate juice was shown to limit the growth of lung, colon, skin and breast cancer. Pomegranate juice improved significantly the myocardial blood-circulation in patients with coronary heart disease and reduced arteriosclerotic lesions of the carotis. It reduces inflammation (through NF-kappa-B and TNF-alpha) and the tendency to develop Alzheimer's disease. Rather than being the result of one particular component, these effects are due to the synergistic activity of all natural biochemical ingredients of the fruit, which modulate cellular signal transduction pathways as well as epigenetic expression and regulation. Pomegranate juice and fermented holistic extracts of the fruit have shown a significantly far greater anti-cancerogenic effect than extracts of isolated pomegranate components such as punicalagin, ellagic acid or tannin rich extracts.

Schlüsselwörter

Granatapfel - Arteriosklerose - Krebs - Immunmodulation von Entzündungsprozessen

Keywords

Pomegranate - arteriosclerosis - cancer - anti-inflammatory immune-modulation

Literatur

• 01 Abd El Wahab S M, Fiki N M, Mostafa S F, Hassan A E B. Characterization of certain steroid hormones in Punica granatum L. seeds.  Bull. Fac. Pharm. (Cairo University). 1998;  36 (1) 11-15
• 02 Adams L S, Seeram N P, Aggarwal B B, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells.  Journal of Agricultural and Food Chemistry. 2006;  54 980-985
• 03 Afaq F, Malik A, Syed D, Maes D, Matsui M S, Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappaB in normal human epidermal keratinocytes paragraph sign.  Photochemistry and Photobiology. 2005;  81 38-45
• 04 Afaq F, Saleem M, Krueger C G, Reed J D, Mukhtar H. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice.  International Journal of Cancer. 2005;  113 423-433
• 05 Ahmed S, Wang N, Hafeez B B, Cheruvu V K, Haqqi T M. Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro.  Journal of Nutrition. 2005;  135 2096-2102
• 06 Albrecht M. et al . Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells.  Journal of Medicinal Food. 2004;  7 274-283
• 07 Ajaikumar A B, Asheef M, Babu B H, Padikkala J. The inhibition of gastric mucosal injury by Punica granatum L. (pomegranate) methanolic extract.  Journal of Ethnopharmacology. 2005;  96 171-176
• 08 Aviram M. et al. . Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice.  American Journal of Clinical Nutrition. 2000;  71 1062-1076
• 09 Aviram M. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation.  Clinical Nutrition. 2004;  23 423-433
• 10 Azadzoi K M, Schulman R N, Aviram M, Siroky M B. Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants.  Journal of Urology. 2005;  174 386-393
• 11 Azmi A S, Bhat S H, Hanif S, Hadi S M. Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties.  FEBS Lett. 2006;  23, 580 (2) 533-538
• 12 Boukef K, Souissi H R, Balansard G. Contribution to the study of plants used in traditional medicine in Tunisia.  Plant Medicine and Phytotherapy. 1982;  16 260-279
• 13 Brewer G J. et al. . Treatment of metastasic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I Study.  Clinc. Cancer Res.. 2000;  6 1-10
• 14 Caceres A, Giron L M, Alvarado S R, Torres M F. Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases.  Journal of Ethnopharmacology. 1987;  20 223-237
• 15 Cerda B, Ceron J J, Tomas-Barberan F A, Espin J C. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic.  J Agric Food Chem.. 2003;  51 (11) 3493-3501
• 16 Cerda B, Espin J C, Parra S, Martinez P, Tomas-Barberan F A. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.  European Journal of Nutrition. 2004;  43 205-220
• 17 Choi D W. Identification of steroid hormones in pomegranate (Punica granatum) using HPLC and GC-mass spectrometry.  Food Chemistry. 2006;  96 (4) 562-571
• 18 Coates R J, Weiss N S, Daling J R, Rettmer R L, Warnick G R. Cancer risk in relation to serum copper levels.  Cancer Res. 1989;  49 4353-4356
• 19 Cunningham K S, Gotlieb A I. The role of shear stress in the pathogenesis of atherosclerosis.  Laboratory Investigation. 2005;  85 9-23
• 20 Czyz J, Madeja Z, Irmer U, Korohoda W, Hulser D F. Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro.  International Journal of Cancer. 2005;  114 12-18
• 21 Dai Q, Borenstein A R, Wu Y, Jackson J C, Larson E B. Fruit and vegetable juices and Alzheimer's disease: the Kame Project.  Am J Med. 2006;  119 (9) 751-759
• 22 De Nigris F. et al. . Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis.  Cardiovasc Res. 2007;  73 (2) 414-423
• 23 De Nigris F. et al. . Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress.  Proceedings of the National Academy of Sciences USA. 2005;  102 4896-4901
• 24 De Nigris F, Williams-Ignarro S, Botti C, Sica V, Ignarro L J, Napoli C. Pomegranate juice reduces oxidized low-density lipoprotein downregulation of endothelial nitric oxide synthase in human coronary endothelial cells.  Nitric Oxide. 2006;  11
• 25 Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L. Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia.  Int J Vitam Nutr Res. 2006;  76 (3) 147-151
• 26 Fang M, Chen D, Yang C S. Dietary polyphenols may affect DNA methylation.  J Nutr. 2007;  137 (S 1) 223S-228S
• 27 Farkas D. Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice.  Pharmacol. 2007;  47 (3) 286-294
• 28 Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors.  Annals of Surgery. 1972;  175 409-416
• 29 Forest C P, Padma-Nathan H, Liker H R. Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, crossover study.  Int J Impot Res. 2007;  14
• 30 Fuhrman B, Volkova N, Aviram M. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages.  J Nutr Biochem. 2005;  16 (9) 570-576
• 31 Gaig P, Botey J, Gutierrez V, Pena M, Eseverri J L, Marin A. Allergy to pomegranate (Punica granatum).  J Investig Allergol Clin Immunol. 1992;  2 (4) 216-218
• 32 Gaig P, Bartolome B, Lleonart R, Garcia-Ortega P, Palacios R, Richart C. Allergy to pomegranate (Punica granatum).  Allergy. 1999;  54 287-288
• 33 Gil M I, Tomas-Barberan F A, Hess-Pierce B, Holcroft D M, Kader A A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.  Journal of Agricultural and Food Chemistry. 2000;  48 4581-4589
• 34 Girolami A, Agostino D, Cliffton E E. The effect of ellagic acid on coagulation in vivo.  Blood. 1966;  27 (1) 93-102
• 35 Gujral M L, Varma D R, Sareen K N. Oral contraceptives . Part 1. Preliminary observations on the antifertility effect of some indigenous drugs.  Indian Journal of Medical Research. 1960;  48 46-51
• 36 Hadi S M, Bhat S H, Azmi A S, Hanif S, Shamim U, Ullah M F. Oxidative breakage of cellular DNA by plant polyphenols: A putative mechanism for anticancer properties.  Semin Cancer. Biol.. 2007;  10
• 37 Hartman R E. et al . Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer’s disease.  Neurobiol Dis. 2006;  24 (3) 506-515
• 38 Hidaka M. et al. . Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats.  Drug Metab Dispos. 2005;  33 (5) 644-648
• 39 Hora J J, Maydew E R, Lansky E P, Dwivedi C. Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice.  Journal of Medicinal Food. 2003;  6 157-161
• 40 Hong S J, Kim S I, Kwon S M, Lee J R, Chung B C. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia.  Yonsei Med J. 2002;  43 236-241
• 41 Huang T H. et al. . Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.  British Journal of Pharmacology. 2005;  145 767-774
• 42 Huang T H. et al. . Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component.  Toxicology and Applied Pharmacology. 2005;  207 160-169
• 43 Huang T H. et al. . Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways.  Journal of Cardiovascular Pharmacology. 2005;  46 856-862
• 44 Huang Y T, Lee L T, Lee P P, Lin Y S, Lee M T. Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability.  Anticancer Research. 2005;  25 2017-2025
• 45 Igea J M. et al . Adverse reaction to pomegranate ingestion.  Allergy. 1991;  46 472-474
• 46 Ignarro L J, Byrns R E, Sumi D, de Nigris F, Napoli C. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide.  Nitric Oxide. Epub. 2006; 
• 47 Jochle W. Biology and pathology of reproduction in Greek mythology.  Contraception. 1971;  4 13
• 48 Jung K H. et al. . Suppressive effect of Punica granatum on the production of tumor necrosis factor (Tnf) in BV2 microglial cells.  Biological and Pharmaceutical Bulletin. 2006;  29 1258-1261
• 49 Kaplan M. et al. . Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis.  J Nutr. 2001;  131 (8) 2082-2089
• 50 Kaur G, Jabbar Z, Athar M, Alam M S. Punica granatum (pomegranate) flower extract possesses potent antioxidant activity and abrogates Fe-NTA induced hepatotoxicity in mice.  Food and Chemical Toxicology. 2006; 
• 51 Kawaii S, Lansky E P. Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells.  Journal of Medicinal Food. 2004;  7 13-18
• 52 Kennedy T. et al. . Copper-dependent inflammation and nuclear factor-KB activation by particulate air pollution.  American journal of respiratory cell and molecular biology. 1998;  19 366-378
• 53 Khan N, Hadi N, Afaq F, Syed D N, Kweon M H, Mukhtar H. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice.  Carcinogenesis. 2007;  28 (1) 163-173
• 54 Khan N, Afaq F, Kweon M H, Kim K, Mukhtar H. Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.  Cancer Res. 2007;  67 (7) 3475-3482
• 55 Kim N D. et al . Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer.  Breast Cancer Research and Treatment. 2002;  71 203-217
• 56 Kim H, Yoon Y J, Shon J H, Cha I J, Shin J G, Liu K H. Inhibitory effects of fruit juices on CYP3A activity.  Drug Metab Dispos. 2006;  34 (4) 521-523
• 57 Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyashita K, Tanaka T. Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats.  Cancer Science. 2004;  95 481-486
• 58 Lad V, Frawley D. The Yoga of Herbs. Santa Fe; NM Lotus Press 1986: 135-136
• 59 Lansky E P. et al. . Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions.  Investigational New Drugs. 2005;  23 11-20
• 60 Lansky E P, Harrison G, Froom P, Jiang W G. Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel.  Investigational New Drugs. 2005;  23 121-122
• 61 Lansky E P, Newman R A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer.  J Ethnopharmacol. 2007;  109 (2) 177-206
• 62 Lansky E P. Beware of pomegranates bearing 40 % ellagic acid.  J Med Food. 2006;  9 (1) 119-122
• 63 Larrosa M, Tomas-Barberan F A, Espin J C. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway.  The Journal of Nutritional Biochemistry. 2005; 
• 64 Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa M T, Tomas-Barberan F A, Espin J C. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities.  J Agric Food Chem. 2006;  54 (5) 1611-1620
• 65 Levin G M. Pomegranate (Punica granatum) plant genetic resources in Turkmenistan.  Plant Genetic Resources Newsletter. 1994;  97 31-37
• 66 Li Y. et al. . Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats.  J Ethnopharmacol. 2005;  99 (2) 239-244
• 67 Liu R H. Potential synergy of phytochemicals in cancer prevention: mechanism of action.  J Nutr. 2004;  134 (S 12) 3479S-3485S
• 68 Loren D J, Seeram N P, Schulman R N, Holtzman D M. Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury.  Pediatric Research. 2005;  57 858-864
• 69 Lowndes S A, Harris A L. The role of copper in tumour angiogenesis.  J Mammary Gland Biol Neoplasia. 2005;  10 (4) 299-310
• 70 Malik A, Afaq F, Sarfaraz S, Adhami V M, Syed D N, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer.  Proceedings of the National Academy of Sciences USA. 2005;  102 14813-14818
• 71 Malik A, Azam S, Hadi N, Hadi S M. DNA degradation by water extract of green tea in the presence of copper ions: implications for anticancer properties.  Phytother Res. 2003;  17 (4) 358-363
• 72 Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.  Am J Clin Nutr. 2005;  81 (S 1) 230S-242S
• 73 Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability.  Am J Clin Nutr. 2004;  79 (5) 727-747
• 74 Maubach J. et al. . Quantitation of soy-derived phytoestrogens in human breast tissue and biological fluids by high-performance liquid chromatography.  J Chromatogr B Anal Technol Biomed Life Sci. 2003;  784 137-144
• 75 Mehta R, Mehta E P. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture.  European Journal of Cancer Prevention. 2004;  13 345-348
• 76 Milner J A. Nutrition and Gene Regulation, Molecular Targets for Bioactive Food Components.  The Journal of Nutrition. 2004;  2492S-2498S
• 77 Milner J A. Diet and Cancer: Facts and Controversies.  Nutrition and Cancer. 2006;  56 (2) 216-224
• 78 Moskaug J O, Carlsen H, Myhrstad M C, Blomhoff R. Polyphenols and glutathione synthesis regulation.  Am J Clin Nutr. 2005;  81 (S 1) 277S-283S
• 79 Mori-Okamoto J, Otawara-Hamamoto Y, Yamato H, Yoshimura H. Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice.  Journal of Ethnopharmacology. 2004;  92 93-101
• 80 Nagaraju N, Rao K N. A survey of plant crude drugs of Rayalaseema, Andhra Pradesh, India.  Journal of Ethnopharmacology. 1990;  29 137-158
• 81 Nayak Shivananda B, Bhat Vinutha R, Upadhyay Dinesh, Udupa Saraswati L. Copper and ceruloplasmin status in serum of prostate and colon cancer patients.  Indian Journal of Physiology and Pharmacology. 2003;  47 (1) 108-110
• 82 Neurath A R, Strick N, Li Y Y, Debnath A K. Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide.  BMC Infect. Dis. Oct.. 2004;  4 41
• 83 Neurath A R, Strick N, Li Y Y, Debnath A K. Punica granatum (pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide.  Ann NY Acad Sci. 2005;  1056 311-237
• 84 Pantuck A J. et al. . Phase II Study of Pomegranate Juice forMen with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer.  Clin Cancer Res. 2006;  12 (13) 4018-4026
• 85 Persichini T, Percario Z, Mazzon E, Colasanti M, Cuzzocrea S, Musci G. Copper activates the NT-kappaB pathway in vivo.  Antioxid Redox Signal. 2006;  8, 9-10 1897-1904
• 86 Polagruto J A, Schramm D D, Wang-Polagruto J F, Lee L, Keen C L. Effects of flavonoid-rich beverages on prostacyclin synthesis in humans and human aortic endothelial cells: association with ex vivo platelet function.  Journal of Medicinal Food. 2003;  6 301-308
• 87 Reddy M K, Gupta S K, Jacob M R, Khan S I, Ferreira D. Antioxidant, Antimalarial and Antimicrobial Activities of Tannin-Rich Fractions, Ellagitannins and Phenolic Acids from Punica granatum L.  Planta Med. 2007; 
• 88 Rosenblat M, Hayek T, Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages.  Atherosclerosis. 2006;  187 (2) 363-371
• 89 Rozenberg O, Howell A, Aviram M. Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it.  Atherosclerosis. 2006;  188 (1) 68-76
• 90 Saxena A, Vikram N K. Role of selected Indian plants in management of type 2 diabetes: a review.  Journal of Alternative and Complementary Medicine. 2004;  10 369-378
• 91 Schubert S Y, Lansky E P, Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids.  J Ethnopharmacol. 1999;  66 (1) 11-17
• 92 Schubert S Y, Neeman I, Resnick N. A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants.  The Federation of American Societies for Experimental Biology Journal. 2002;  16 1931-1933
• 93 Seeram N P, Lee R, Heber D. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice.  Clin Chim Acta. 2004;  348 (1-2) 63-68
• 94 Seeram N P. et al. . In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice.  Journal of Nutritional Biochemistry. 2005;  16 360-367
• 95 Seeram N P, Schulman R N, Heber D. Pomegranates: Ancient Roots to Modern Medicine. Boca Raton, Florida, USA; Taylor and Francis CRC Press 2006
• 96 Settheetham W, Ishida T. Study of genotoxic effects of antidiarrheal medicinal herbs on human cells in vitro.  The Southeast Asian Journal of Tropical Medicine and Public Health. 1995;  26 (S 1) 306-310
• 97 Sorokin A V, Duncan B, Panetta R, Thompson P D. Rhabdomyolysis associated with pomegranate juice consumption.  Am J Cardiol. 2006;  98 (5) 705-706
• 98 Squillaci G, Di Maggio G. [Acute morbidity and mortality from decoctions of the bark of Punica granatum].  Bollettino Societa Italiana Biologia Sperimentale. 1946;  1095-1096
• 99 Spiegel. Medizin. Weltformel des Stoffwechsels.  2004;  46
• 100 Sumner M D. et al. . Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease.  Am J Cardiol. 2005;  96 (6) 810-814
• 101 Syed D N, Malik A, Hadi N, Sarfaraz S, Afaq F, Mukhtar H. Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cellular pathways in normal human epidermal keratinocytes.  Photochem Photobiol. 2006;  82 (2) 398-405
• 102 Toi M. et al. . Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo.  Angiogenesis. 2003;  6 121-128
• 103 Trepels T, Zeiher A M, Fichtischerer S. Acute Coronary Syndrome and Inflammation. Biomarkers for Diagnostics and Risk Stratification.  Herz. 2004;  29 (8) 769-776
• 104 Valko M, Rhodes C J, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer.  Chem Biol Interact. 2006;  160 (1) 1-40
• 105 Valsecchi R, Reseghetti A, Leghissa P, Cologni L, Cortinovis R. Immediate contact hypersensitivity to pomegranate.  Contact Dermatitis. 1998;  38 (1) 44-45
• 106 Vattem D A, Shetty K. Biological Functionality of ellagic acid: a review.  Journal of Food Biochemistry. 2005;  29 234-266
• 107 Vidal A. et al. . Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit extracts.  Journal of Ethnopharmacology. 2003;  89 295-300
• 108 Wang R, Wei Wang, Wang L, Liu R, Yi Ding, Du L. Constituents of the flowers of Punica granatum.  Fitoterapia. 2006;  77 (7-8) 534-537
• 109 Way T D, Kao M C, Lin J K. Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells.  FEBS Letters. 2005;  579 145-152
• 110 Wu T J, Sempos C T, Freudenheim J L, Muti P, Smith E. Serum iron, copper and zinc concentrations and risk of canacer mortality in US adults.  Ann. Epidemiol.. 2004;  14 195-201
• 111 Zand R S, Jenkins D J, Diamandis E P. Steroid hormone activity of flavonoids and related compounds.  Breast Cancer Research and Treatment. 2000;  62 35-49
• 112 Zhan B. Multifunctional vaginal suppository for contraception, etc. Chinese Patent CN 1103789A 1995
• 113 Zhang J, Zhan B, Yao X, Song J. Antiviral activity of tannin from the pericarp of Punica granatum L. against genital herpes virus in vitro.  Zhongguo Zhongyao Zazhi. 1995;  20 556-558
• 114 Zheng P W, Chiang L C, Lin C C. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells.  Life Sciences. 2005;  76 1367-1379
• 115 Zhou S, Lim L Y, Chowbay B. Herbal modulation of P-glycoprotein.  Drug Metab Rev. 2004;  36 (1) 57-104

Korrespondenzadresse